Monoclonal T-Cell Receptors: New Reagents for Cancer Therapy

This publication has 72 references indexed in Scilit:

• Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes
  Proceedings of the National Academy of Sciences, 2004
• Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
  Science, 2002
• Infusion of cytomegalovirus (CMV)–specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy
  Blood, 2002
• COMPLETE REGRESSION OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE USING PARTIALLY HLA-MATCHED EPSTEIN BARR VIRUS-SPECIFIC CYTOTOXIC T CELLS1
  Transplantation, 2001
• Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients
  Blood, 1998
• Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
  New England Journal of Medicine, 1995
• Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation
  The Lancet, 1995
• Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
  Blood, 1990
• Graft-versus-leukemia reactions after bone marrow transplantation
  Blood, 1990
• Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
  New England Journal of Medicine, 1988